Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
TCF7L2 is a master regulator of insulin production and processing
Show others and affiliations
2014 (English)In: Human Molecular Genetics, ISSN 0964-6906, E-ISSN 1460-2083, Vol. 23, no 24, 6419-6431 p.Article in journal (Refereed) Published
Abstract [en]

Genome-wide association studies have revealed > 60 loci associated with type 2 diabetes ( T2D), but the underlying causal variants and functional mechanisms remain largely elusive. Although variants in TCF7L2 confer the strongest risk of T2D among common variants by presumed effects on islet function, the molecular mechanisms are not yet well understood. Using RNA-sequencing, we have identified a TCF7L2-regulated transcriptional network responsible for its effect on insulin secretion in rodent and human pancreatic islets. ISL1 is a primary target of TCF7L2 and regulates proinsulin production and processing via MAFA, PDX1, NKX6.1, PCSK1, PCSK2 and SLC30A8, thereby providing evidence for a coordinated regulation of insulin production and processing. The risk T-allele of rs7903146 was associated with increased TCF7L2 expression, and decreased insulin content and secretion. Using gene expression profiles of 66 human pancreatic islets donors', we also show that the identified TCF7L2-ISL1 transcriptional network is regulated in a genotype-dependent manner. Taken together, these results demonstrate that not only synthesis of proinsulin is regulated by TCF7L2 but also processing and possibly clearance of proinsulin and insulin. These multiple targets in key pathways may explain why TCF7L2 has emerged as the gene showing one of the strongest associations with T2D.

Place, publisher, year, edition, pages
2014. Vol. 23, no 24, 6419-6431 p.
National Category
Biochemistry and Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-245536DOI: 10.1093/hmg/ddu359ISI: 000347921900001PubMedID: 25015099OAI: oai:DiVA.org:uu-245536DiVA: diva2:793902
Funder
Swedish Research Council, 2007-4037, 2009-2001, 2007-5721, 2008-6589, 2009-1039Knut and Alice Wallenberg Foundation, KAW 2009.0243EU, FP7, Seventh Framework Programme, Health-2008-223211Swedish Diabetes Association, 2009-060
Available from: 2015-03-09 Created: 2015-02-26 Last updated: 2017-12-04Bibliographically approved

Open Access in DiVA

fulltext(1000 kB)101 downloads
File information
File name FULLTEXT01.pdfFile size 1000 kBChecksum SHA-512
574cd205544adcf5fdec0782d203138a2ac4cc9168ff3a008d2215520145c2b916be4cf3c20be6ebe3a41174123013107c318858c4c4772f0030957605079ded
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Rung, Johan

Search in DiVA

By author/editor
Rung, Johan
By organisation
Department of Immunology, Genetics and Pathology
In the same journal
Human Molecular Genetics
Biochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 101 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 422 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf